UK backs AstraZeneca nasal flu vaccine for all kids

LONDON (Reuters) – Britain is to extend its seasonal flu vaccination program to all children, free of charge, becoming the first country in the world to do so, the Department of Health said on Wednesday. Children will get AstraZeneca’s nasal spray vaccine, rather than injections, under the new scheme. The roll-out will take time, however, since the drugmaker will not have the capacity to deliver enough new vaccine until 2014 at the earliest. …

EU regulators charge Lundbeck, others over generics

BRUSSELS (Reuters) – EU antitrust regulators charged Danish drugmaker Lundbeck, German peer Merck and seven other firms with blocking the entry of cheaper generic medicines into the market in a move that could lead to fines for the companies. The European Commission said on Wednesday the tactic breached EU antitrust rules. It also warned of further action against French drugmaker Servier and several generic rivals in the coming days for a similar offence, related to another medicine. Reuters had reported on Tuesday that the EU watchdog would act against Lundbeck and Servier. …

World’s first dengue vaccine beats three virus strains

PARIS/LONDON (Reuters) – The world’s first vaccine against dengue, developed by French drugmaker Sanofi SA, has shown the ability to protect against disease caused by three of four virus strains in a keenly awaited clinical trial in Thailand. Sanofi said on Wednesday the proof of efficacy was a key milestone in the 70-year quest to develop a viable dengue shot, adding the results also confirmed the safety profile of the vaccine candidate. Other drug companies are also working on dengue vaccines but Sanofi’s product is several years ahead. …

Bayer in talks to sell diabetes device unit: paper

FRANKFURT (Reuters) – Germany’s largest drugmaker Bayer AG is in talks to sell its blood glucose meters business, Financial Times Deutschland reported, citing industry and financial sources. The paper said on Wednesday Bayer had mandated Credit Suisse to handle the sale. It said parties interested in the business included France’s Sanofi and Japan’s Panasonic. A spokeswoman for electronics group Panasonic denied it was looking at the business. Sanofi, Bayer and Credit Suisse were not immediately available for comment. …

1 24 25 26 27 28 121